Pharma Inc. has two product lines organized as divisions (Pain Reliever and Weight Loser) and spends heavily on research and development (R&D) activities. The following information is related to Pharma Inc's second year of operations. Pain Reliever $450,000 $300,000 Weight Loser R&D expenditures (second year) After-tax income Current liabilities Divisional investment 1,365,000 982,000 Cost of capital In the first year, Pain Reliever spent $300,000 on R&D, while Weight Loser spent $150,000. Pharma Inc. estimates that R&D expenditures have a three-year life to be amortized according to the following schedule: 1/6 in the year incurred, 1/3 in the next two years, and 1/6 in the fourth year after the initial spending. Required: Calculate EVA for the two divisions of Pharma Inc. for its second year of operations. 275,000 584,000 $210,000 397,000 23% 23%

Essentials Of Investments
11th Edition
ISBN:9781260013924
Author:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Chapter1: Investments: Background And Issues
Section: Chapter Questions
Problem 1PS
icon
Related questions
Question
Pharma Inc. has two product lines organized
as divisions (Pain Reliever and Weight Loser)
and spends heavily on research and
development (R&D) activities. The following
information is related to Pharma Inc's second
year of operations.
Pain
Reliever
$450,000 $300,000
Weight
Loser
R&D expenditures
(second year)
After-tax income
Current liabilities
Divisional investment 1,365,000 982,000
Cost of capital
In the first year, Pain Reliever spent $300,000
on R&D, while Weight Loser spent $150,000.
Pharma Inc. estimates that R&D expenditures
have a three-year life to be amortized
according to the following schedule: 1/6 in the
year incurred, 1/3 in the next two years, and
1/6 in the fourth year after the initial
spending.
Required:
Calculate EVA for the two divisions of Pharma
Inc. for its second year of operations.
275,000
584,000
$210,000
397,000
23%
23%
Transcribed Image Text:Pharma Inc. has two product lines organized as divisions (Pain Reliever and Weight Loser) and spends heavily on research and development (R&D) activities. The following information is related to Pharma Inc's second year of operations. Pain Reliever $450,000 $300,000 Weight Loser R&D expenditures (second year) After-tax income Current liabilities Divisional investment 1,365,000 982,000 Cost of capital In the first year, Pain Reliever spent $300,000 on R&D, while Weight Loser spent $150,000. Pharma Inc. estimates that R&D expenditures have a three-year life to be amortized according to the following schedule: 1/6 in the year incurred, 1/3 in the next two years, and 1/6 in the fourth year after the initial spending. Required: Calculate EVA for the two divisions of Pharma Inc. for its second year of operations. 275,000 584,000 $210,000 397,000 23% 23%
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps with 2 images

Blurred answer
Knowledge Booster
Ratio Analysis
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
Essentials Of Investments
Essentials Of Investments
Finance
ISBN:
9781260013924
Author:
Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:
Mcgraw-hill Education,
FUNDAMENTALS OF CORPORATE FINANCE
FUNDAMENTALS OF CORPORATE FINANCE
Finance
ISBN:
9781260013962
Author:
BREALEY
Publisher:
RENT MCG
Financial Management: Theory & Practice
Financial Management: Theory & Practice
Finance
ISBN:
9781337909730
Author:
Brigham
Publisher:
Cengage
Foundations Of Finance
Foundations Of Finance
Finance
ISBN:
9780134897264
Author:
KEOWN, Arthur J., Martin, John D., PETTY, J. William
Publisher:
Pearson,
Fundamentals of Financial Management (MindTap Cou…
Fundamentals of Financial Management (MindTap Cou…
Finance
ISBN:
9781337395250
Author:
Eugene F. Brigham, Joel F. Houston
Publisher:
Cengage Learning
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Finance
ISBN:
9780077861759
Author:
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
Publisher:
McGraw-Hill Education